Previous 10 | Next 10 |
home / stock / avcnf / avcnf news
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. (the “ Compan...
NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the March 25 th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and in...
Avicanna has been granted its 2021 quota from the Colombian government to cultivate and process up to 10,267 kg of dry flower for exports in the form of crude and standardized extracts and final phyto-therapeutic pharmaceutical products and to produce seeds from registered psychoactive ...
Flora Growth has filed to raise $15 million in an IPO. The firm is a cannabis and hemp grower in Colombia. FLGC has scant revenue history so it is difficult to determine if the IPO is reasonably valued; I'll watch it from the sidelines. For further details see: Flora Gro...
TORONTO, March 25, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. (" Avicanna " or the " Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to anno...
Avicanna ([[AVCNF]] +2.5%) entered into an intellectual property licensing and royalty agreement with VB Brands California for using the Viola brand in connection with specific formulations developed by Avicanna that are intended to be commercialized in Canada through medical and co...
Purpose-driven cannabis brand rooted in social equity and justice to enter Canada Avicanna to lead commercialization through medical and consumer retail sales channels Viola intends to promote various social projects to advance education related to cannabis as well as ...
TORONTO, March 22, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, today announced that Aras Azadian, Chief Executive...
NEW YORK , March 19, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations an...
TORONTO, March 15, 2021 (GLOBE NEWSWIRE) -- We are advised by Avicanna Inc. that journalists and other readers should disregard the news release, “Avicanna to present at the Q1 Virtual Investor Summit” issued March 11, 2021, over GlobeNewswire.
News, Short Squeeze, Breakout and More Instantly...
This marks the first export into Asia, the 18 th international market for Aureus branded products and 21 st market for all Avicanna products TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. ( “Avicanna” or the “Company” ...
TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based prod...
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor Forum held June 20 th are now available for online viewing. REGISTER NOW AT : ...